The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

Investigators assessed the prevalence of adverse pregnancy outcomes among women with spondyloarthritis vs a matched general-population cohort.

HealthDay News — With the end of federal health insurance subsidies, President Donald Trump has floated a new plan aimed at ...

HealthDay News — The count and rate of emergency department (ED) visits for alcohol-specific diagnoses increased from ...

Early childhood is a key period for immune maturation, yet evidence linking early animal exposures with the development of ...

HealthDay News — Between 2019 and 2024, there was a decline in skilled nursing facility (SNF) capacity, with a decrease in ...

Prioritizing nonpharmacologic strategies, enhancing staff training, and distinguishing Delirium Superimposed on Dementia (DSD) are vital to improving outcomes for hospitalized patients with Alzheimer ...

Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.

More than 2700 grants that support programs that provide care for mental illness, substance use disorders, and recovery were briefly terminated before the decision was stopped. HealthDay News — ...

Significant predictors for prescribing DMPA-SC included being gender-diverse or male, having access to DMPA-SC-specific clinical workflows, and having state Medicaid and private insurance coverage for ...